Our findings are consistent with reports showing that JAK-STAT-mediated chronic inflammation in pancreatic cancer impairs cytotoxic T-lymphocyte activation, thereby reducing the effectiveness of anti-PD-1 immunotherapy 48. Here, SOAT1 is linked to pancreatic neoplasm.